IMPL

Impel Pharmaceuticals Inc. Common Stock
IMPL

Overview Fund Activity
Delisted

IMPL was delisted on the 15th of December, 2023.

Back to rankings

2 hedge funds and large institutions have $341K invested in Impel Pharmaceuticals Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.

Holders
2
Holders Change
-30
Holders Change %
-93.75%
% of All Funds
0.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
–
Increased
–
Reduced
–
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$0
2
NA
2
NVP Associates
California
$0
3
5VM
3
5AM Venture Management
California
$0
4
VC
4
Vivo Capital
California
$0
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– -$860 -2,000 Closed
UBS Group
27
UBS Group
Switzerland
– -$621 -1,445 Closed
Osaic Holdings
28
Osaic Holdings
Arizona
– -$247 -575 Closed
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
– -$154 -359 Closed
Wells Fargo
30
Wells Fargo
California
– -$25 -57 Closed
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
– -$2 -4 Closed
1
2